Good News for breast cancer sufferers
Image: Tumour Heterogeneity The NHS in UK has finally approved Kadcyla, Roche Pharmaceuticals breast cancer drug, for routine use after a four-year campaign. The drug extends the lives of women with advanced forms of breast cancer by some six months. It was hitherto only available on a case-by-case basis through the Cancer Drugs Fund because…